Furthermore, our lyophilised format ensures long-term stability for extended research use
This isnt about willpower, its about addressing hormonal root causes with science-backed treatment
La integracin en el tratamiento, la frecuencia de uso y la combinacin con otros activos deben definirse segn valoracin profesional
High levels of estradiol, the predominant type of estrogen produced by the ovaries, early in the menstrual cycle can be an indicator of HPO axis dysfunction
Some people may experience mild injection-site pain, headache, nausea, or dizziness
days 1 to 30): 1.5 mg orally once a day Dose escalation (days 31 to 60): 4 mg orally once a day Maintenance dose (day 61 and onward): If no additional glycemic control is needed: Maintain at 4 mg orally once a day